# OnCo record paper-ifda-drug-lag-alipour-medicine-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ifda-drug-lag-alipour-medicine-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ifda-drug-lag-alipour-medicine-2024" ;
  schema:name "Assessing drug lag in new drug approvals by the Iran Food and Drug Administration compared to the U.S. FDA, EMA, and PMDA: a 20-year analysis (2001-2021)"@en ;
  schema:description "New medicines approved in the United States from 2001 to 2021 reached approval in Iran, when they did at all, more than five years later on average, and cancer medicines were no faster."@en ;
  schema:url <https://onco.cc/key-papers/paper-ifda-drug-lag-alipour-medicine-2024/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1097/MD.0000000000038142>, <https://pubmed.ncbi.nlm.nih.gov/38905367/> ;
  schema:sameAs <https://doi.org/10.1097/MD.0000000000038142> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Alipour S, Nadimi Parashkouhi S, Mojahedian M, Abbasian H" ;
  onco:institutions <https://onco.cc/institutions/iran-fda/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-regulatory-fragmentation/> .